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Background. Although itch and pain are distinct experiences, both are unpleasant, may demand attention, and interfere with daily
activities. Research investigating the role of attention in tonic itch and pain stimuli, particularly whether attention is drawn to
the stimulus location, is scarce. Methods. In the somatosensory attention task, fifty-three healthy participants were exposed to
35-second electrical itch or pain stimuli on either the left or right wrist. Participants responded as quickly as possible to visual
targets appearing at the stimulated location (ipsilateral trials) or the arm without stimulation (contralateral trials). During control
blocks, participants performed the visual task without stimulation. Attention allocation at the itch and pain location is inferred
when responses are faster ipsilaterally than contralaterally. Results. Results did not indicate that attention was directed towards or
away from the itch and pain location. Notwithstanding, participants were slower during itch and pain than during control blocks.
Conclusions. In contrast with our hypotheses, no indications were found for spatial attention allocation towards the somatosensory
stimuli. This may relate to dynamic shifts in attention over the time course of the tonic sensations. Our secondary finding that itch
and pain interfere with task performance is in-line with attention theories of bodily perception.
1. Introduction
Itch and pain are common somatosensory sensations, which,
in acute form, function to protect body integrity, for example,
penetration of the skin or stinging insects [1]. When chronic,
for example, due to chronic inflammatory conditions of the
skin, joints, or viscera, they often have a serious impact on
quality of life and performance in daily activities [2–4]. One
of the primary reasons for this burden is that itch and pain
demand attention in order to perform their protective role
[1, 5–7]. For example, when we touch a sharp object or red
ants crawl on our skin, fast detection and identification of
the threat along with interruption from a concurrent task are
adaptive as we can impose action to prevent bodily damage.
The interplay between attention and pain has frequently
been investigated. The interplay between attention and itch,
however, has barely received attention.
Leading cognitive frameworks on pain, which might to
some extent also apply for itch, propose that pain draws
attention and as such interrupts ongoing task performance
and goal pursuit [7–12]. Overall, studies indicate that patients
with chronic pain attend more to pain-related stimuli than
control participants and have difficulties disengaging their
attention away from pain [5, 6]. Such impaired ability to
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disengage attention from pain or pain-related information is
believed to detrimentally affect functioning in daily activities
[5–7]. Pain interfereswith task performance [13–18], probably
by directing attention to the location where the pain is
expected and/or experienced. More recently, studies have
focused upon the spatial attention allocation in pain [19–27].
It was found that attention was directed to the bodily location
where threatening somatosensory stimuli were expected to
occur [23–25]. It is reasonable to assume that individual dif-
ferences in catastrophizing, worrying, and pain-related fear
amplify the threat value of somatosensory stimuli and thus
lead to a stronger prioritization of attention [5, 15, 28–32].
Also attempting to control pain leads to a similar allocation of
attention towards the location where somatosensory stimuli
are expected to occur [21, 26]. A heightened level of attention
for pain and its locationmay then intensify the pain sensation
or its impact upon daily functioning [5, 26]. These processes
may also play a role in patients with chronic pain or itch
[9, 10, 33, 34]. With regard to attention and itch, there are
only some indications that itch-related information (e.g.,
words or pictures) draws attention [35–38] and that more
bodily attention is related to heightened itch sensitivity [39].
However, research into spatial allocation of attention while
experiencing itch is limited [38].
The investigation of spatial attention in pain and itch
requires the use of specific paradigms. For example, spatial
attention allocation has been investigated while participants
perceive somatosensory pain stimuli on different locations
while focusing on and responding to the location of tac-
tile/visual/auditory target stimuli that are ipsilateral or con-
tralateral to the pain location (e.g., [19–27]). Attention alloca-
tion to the stimulation location is inferred when participants
respond faster to visual targets displayed ipsilaterally than
on targets displayed contralaterally to stimulation, as can be
deduced from the attentional bias index (i.e., the difference
in response time to the contralateral minus the ipsilateral
targets [20]). Enhanced focusing on the ipsilateral location
is indicative for an attentional engagement, whereas faster
responses on the contralateral location are indicative for dis-
engagement of attention away from the stimulus, and when
the attentional bias index significantly deviates from zero,
there is an attentional bias. It has generally been found that
pain draws attention towards its location, that is, attentional
engagement [19–27].Most of these studies, with the exception
of [27], use phasic stimuli (≤1 s). However, patients often
experience symptoms for a longer duration, stressing the
importance of being able to disengage attention from pain
and focus on activities in daily life. This is not only relevant
for the study of pain, but also for itch, which is a sensation
that is often prolonged by attentional processes, given its
contagiousness [40]. For itch, we developed a somatosensory
attention task (SAT) [38] with tonic itch stimuli of 35 s
during which participants responded as quickly as possible
to visual targets located at the stimulated or nonstimulated
location. We did not find that healthy participants focused
their attention towards the itch location; instead, we found
some indications that participants disengaged their attention
away from the itch location during the second half of the
35 s itch stimuli [38]. However, given the discrepancy with
previous findings for pain showing that pain draws attention
to its location, additional research involving both tonic itch
and pain is required.
The aim of the present study was to investigate whether
healthy participants focus their attention at or away from the
tonic itch and pain stimulus location. It was expected that
the participants’ attention would be drawn to the location
of the itch and pain stimuli early on but later on during
the stimulation would disengage their attention from the
stimulated location. Additionally, the relationship between
attentional processing of itch and pain and other psycholog-
ical characteristics, specifically self-reported catastrophizing,
neuroticism, perceived threat of the somatosensory stimuli,
attention for bodily sensations, and attentional disengage-
ment from itch and pain was explored.
2. Methods
2.1. Participants. Fifty-three healthy volunteers (45 female/8
male; mean age of 22.0 years, SD = 2.2; range 18.6–29.4 years)
were included. Participants were recruited through adver-
tisements at Leiden University and the Leiden University
Research Participation system (SONA systems Ltd., Tallinn,
Estonia). Inclusion criteria for participation were being aged
between 18 and 30 years (with the intention to include a
homogenous group since reaction times increase with age
[41]) and fluent in Dutch language. Exclusion criteria for
participation were being a patient with chronic itch or pain,
severe morbidity (e.g., multiple sclerosis, diabetes mellitus,
heart or lung disease, and vasculitis), psychiatric disorders
(e.g., depression), use of pacemaker, current use of medica-
tion (e.g., analgesics, antihistaminics), and pregnancy. Of the
participants, 73.6% were following or had finished tertiary
education, 24.5% were following or had finished secondary
education, and 1.9% had followed primary education. The
protocol was approved by the local Medical Review Ethics
Committee and all participants provided written informed
consent prior to testing.
2.2. Itch and Pain Induction. Itch and pain were induced
electrically by means of a constant current stimulator (Iso-
lated Bipolar Constant Current Stimulator DS5, Digitimer,
United Kingdom) [37, 38, 42]. For itch induction, two
surface electrodes were attached to the center of the lateral
side of the wrist, a disk electrode (ø 1 cm, VCM Medical,
The Netherlands) 1.5 cm proximal to the triquetrum, and a
reference electrode (ø 2 cm, VCMMedical, the Netherlands)
2 cm proximal [37, 38, 42]. For pain induction, two surface
electrodes (two disk electrodes of ø 1 cm, VCM Medical, the
Netherlands) were attached at the center of the dorsal side of
thewrist [20], one 1.5 cmproximal to the processus styloideus
ulnae and the other 2 cm proximal. In accordance with our
previous studies with electrically induced itch [37, 38, 42],
the stimulus characteristics for the itch stimuli were 50Hz
frequency, 0.1ms pulse duration, and a ramping of 0.05mA/s.
The itch stimuli lasted for at maximum 35 seconds, the
duration of the stimuli in the SAT. For pain, the stimulus
characteristics were partly based on previous studies (e.g.,
[24, 43]) and partly determined by extensive piloting of the
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methods since electrical pain stimuli are not regularly applied
for 35 seconds. Eventually, pain stimuli were applied also
at 50Hz frequency and 0.4ms pulse duration. Alike our
previous studies [37, 38, 42], the maximum current for all
stimuli was 5.00mA. The levels of itch and pain evoked by
each electrical stimulus were scored on a numerical rating
scale (NRS) ranging from 0 (no itch/pain) to 10 (worst
itch/pain ever experienced).
2.2.1. Determination of the Intensity of the Itch Stimuli. In
order to determine the individual intensity at which the
35 s baseline itch stimulus and the itch stimuli during the
SAT were delivered, a step-up procedure was executed with
35 s stimuli starting at 0.25mA, with 0.50mA increments
for every step. For example, the first stimulus started at
0.25mA and, as a consequence of the ramping, ended at
2.00mA; the second started at 0.75mAand ended at 2.50mA.
Because the first step ended relatively high, just before the itch
step-up, familiarization with the stimulation took place by
assessing two perception thresholds starting at 0.01mA and
ending when the participant reported “the moment that you
experience a sensation for the first time” [42]. The step-up
procedure finished when the aimed NRS itch was at least 5
or the maximum defined current intensity of 5.00mA was
reached (i.e., stimulus from 3.25 to 5.00mA). However, in
the case the NRS itch exceeded 7, the current intensity was
decreased with 0.5mA (when NRS itch ≥ 8) or 0.25mA
(when NRS itch ≥ 7) up until the NRS itch was between 5
and 7. In this study, the determined starting current intensity
for the baseline and SAT itch stimuli was on average 2.36 (SD
= 1.26)mA.
2.2.2. Determination of the Intensity of the Pain Stimuli. In
order to determine the individual intensity at which the 35 s
baseline pain stimulus and the pain stimuli during the SAT
were delivered, a step-up procedure was executed with 10 s
stimuli (in order to keep stimulation time better comparable
to the itch step-up procedure which consisted of less steps)
that increased by 0.50mA per step. The first stimulus was
given at 0.50mA, the second at 1.00mA, and so on.The step-
up procedure was finished when the aimed NRS pain was at
least 5 or the maximum defined current intensity of 5.00mA
was reached. However, in the case the NRS pain exceeded
7, the current intensity was decreased with 0.5mA (when
NRS pain ≥ 8) or 0.25mA (when NRS pain ≥ 7) up until the
NRS pain was between 5 and 7. In this study, the determined
current intensity for the 35 s baseline pain stimulus before the
SAT and the pain stimuli during the SAT was on average 3.70
(SD = 1.59)mA.
2.3. Somatosensory Attention Task. Thesomatosensory atten-
tion task (SAT) as used in our previous study [38], which
was based on an attention task developed for pain [20], was
adopted to investigate attention allocation towards both an
itch and pain stimulation and their location (see Figure 1 for a
schematic representation of the setup). A plastic black curved
screen of ca. 50 cm height with 3 LED lights at 10 cm height
(middle green fixation LED, the left and right were red target
LEDs placed at 25 degrees from the middle LED) was placed
Itch 
stimulus
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Response buttons
Pain 
stimulus
Target light
Figure 1: Schematic representation of the setup of the somatosen-
sory attention task. The side of itch stimulation was contralateral
to the pain stimulation (randomized across participants). During
a block, an itch (itch block) or pain (pain block) stimulus was
applied, or no stimulation (control blocks), while, after short onset
of the fixation light, one of the target lights illuminated. Participants
responded to the target light location using response buttons right
below both target lights, at either the ipsilateral or the contralateral
location as opposed to the somatosensory stimulation.
in front of the participant.The LEDs were controlled using E-
prime software version 2.0 (Psychology Software Tools Inc.,
Sharpsburg, PA, USA) on a Dell optiplex 3010 computer with
Philips Brilliance 225 TFT screen (Resolution 1280 × 1024
at 60Hz). Right below the left and right LED there was a
platform with finger response buttons (Pushbutton Switch,
SPDT, Off-(On)) at a fixed position, attached to a serial
response box (Psychology Software Tools Inc. Sharpsburg,
PA, USA).
The SAT consisted of 12 blocks of 35 seconds each, of
which 4 blocks with pain stimuli (pain blocks), 4 blocks with
itch stimuli (itch blocks), and 4 blocks without somatosen-
sory stimulation (control blocks). The order of blocks was
randomized by E-Prime for each participant. The standard
interval between two blocks was 1 minute, which was
extended by 1 minute up to a maximum of 5 minutes in
the case the NRS pain or NRS itch exceeded 2.0. During
each block 10 trials with visual targets were administered, in
which first the fixation light (green LED light) was turned
on for 1000ms and extinguished, and then either the left
or right target (red LED light) was turned on for 200ms
[38], while unilaterally administering itch (itch blocks) or
pain (pain blocks) stimuli, or no stimulation (control blocks).
The response window for participants to press a button was
1500ms. The 10 target stimuli in each block were given in
random order with random time interval (varying between
0 and 2000ms) before the next trial. Half of the visual
targets were presented at the wrist where the electrodes were
attached and itch or pain was applied in the case of itch
and pain block, respectively (“ipsilateral trials”), and half
of the visual targets were presented oppositely (“contralat-
eral trials”). Conforming previous research (e.g., [20]), the
difference in participants’ responding to ipsilateral versus
contralateral trials is a measure of spatial attention allocation
towards the somatosensory stimulus, with faster responses to
ipsilateral trials being indicative for an attentional bias.
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2.4. Self-Report Questionnaires. The following self-report
questionnaires were administered in Dutch using the online
system Qualtrics (Provo, Utah, USA).
The presence of physical symptoms was assessed by visual
analogue scales (VAS) for itch and pain from the Impact of
chronic skin disease on daily life (ISDL) [44], inquiring about
the levels of itch and pain during the past twoweeks on a scale
from 0 (no itch/pain) to 10 (worst itch/pain experienced).
Psychological distress was measured with the Hospital
Anxiety andDepression Scale (HADS) [45] and a short version
of the Positive andNegative Affect Schedule (PANAS) [46].The
HADS consists of 7 items measuring the subscale depression
(Cronbach alpha in the present study was 0.67) and 7 items
measuring the subscale anxiety (Cronbach alpha 0.71), scored
on a scale from 0 to 3. The total score was obtained by
summing the items per subscale. The PANAS consists of
5 positive items (PANAS-PA; Cronbach alpha 0.59) and 5
negative items (PANAS-NA; Cronbach alpha 0.35) scored on
a 5-point Likert scale from 1 to 5. Due to the low reliability,
the PANAS was excluded from data analyses.
Catastrophizing about physical sensations was measured
using the Pain Catastrophizing Scale [47], adjusted for phys-
ical sensations (PCS-A) in order to make it also applicable
to itch (i.e., by substituting the word “pain” for “physical
sensations” for all concerning items). The questionnaire
contained 13 items, which were scored on a 5-point Likert
scale from 0 to 4. The Cronbach alpha for the PCS-A in the
present study was 0.87.
Neuroticism was measured with the Eysenck Personality
Questionnaire revised short scale (EPQ-RSS) [48], consisting
of different subscales, including the subscale neuroticism
(Cronbach alpha = 0.72), which consists of 12 items rated on
a dichotomous scale (yes = 1/no = 0).
Fear of pain was measured using the Fear of Pain
Questionnaire III (FPQ-III) [49], with 30 items assessing
the degree of fear participants would likely experience in
potentially painful situations, subdivided in the categories
severe pain,minor pain, andmedical pain.The items are rated
on a 5-point scale from 1 (not at all fearful of this pain) to 5
(extremely fearful of this pain). Cronbach alpha of the FPQ-
III in the present study was 0.90.
Attentional focus on bodily sensationswasmeasured using
the Body Vigilance Scale (BVS) [39, 50], the Body Sensations
questionnaire [39, 51], and the Pain Vigilance and Awareness
Questionnaire [52] adjusted for physical sensations (i.e., by
substituting the word “pain” by “physical sensations” for all
concerning items) (PVAQ-A) in order to make it broadly
applicable to physical sensations, including itch and pain.The
BVS, used to measure attentional focus on bodily sensations,
contained 4 items, of which the fourth item consisted of 13
subitems about anxiety-related bodily sensations. All items
were rated on a VAS from 0 to 10. Cronbach alpha of the
BVS in the present study was 0.79. Additionally, two items
had been added that assess one’s attention directed towards
itch and pain. Of the BSQ, the 15 items concerning bodily
sensations (omitting the 2 items concerning derealization)
were used to measure of attentional focus on the occurrence
of bodily sensations when in a nervous or feared situation
(e.g., heart palpitations, dizziness or sweating). Participants
used a 5-point Likert scale that ranged from “the sensation
never occurs” (0) to “the sensation occurs almost always
or always” (4). Cronbach alpha of the BSQ in the present
study was 0.79. The PVAQ-A was used to measure attention
to bodily sensations by asking subjects to consider their
behavior in relation to physical sensations. The PVAQ-A
(Cronbach alpha 0.85) consisted of 16 items, for example, “I
focus on physical sensations.” Items were scored on a 6-point
Likert scale (0 never to 5 always).
Attentional disengagement from itch and painwas assessed
using two Likert scales ranging from 1 (not at all able to
disengage attention) to 5 (always able to disengage attention).
In addition to these online questionnaires, participants
indicated the perceived threat of the stimuli applied in the
experiment on a scale from 0 (not threatening) to 10 (very
threatening). Participants also rated the extent to which they
were distracted by the itch or pain stimuli or other factors
during their responses to the visual targets in the SAT on 5-
point Likert scales ranging from 1 (not at all distracted) to 5
(distracted to very large extent).
2.5. Procedure. Potential participants were informed about
the study via written information. When interested in par-
ticipation, they clicked on an online link to fill out several
questions. These concerned demographic variables, absence
or presence of medical or psychiatric conditions, intake of
medication during the past 4weeks, theVAS for itch andpain,
HADS, PCS-A, EPQ-RSS, FPQ-III, BSQ, PVAQ-A, and atten-
tional disengagement from itch and pain (see Section 2.4).
Based on the online assessment, eligibility screening was
performed on inclusion and exclusion criteria. Uncertainties
about eligibility were solved by telephone contact. Eligible
participants made an appointment for participation. Par-
ticipants were instructed to refrain from intake of alcohol
and drugs 24 hours before attending the experiment. Upon
arrival at the test facility, participants were verbally informed
about the procedure and told that they were free to terminate
the experiment at any time. Then participants signed the
informed consent. In the lab, subjects also rated their current
levels of spontaneous itch andpain aswell as perceived fatigue
on an NRS ranging from 0 (no itch/pain/fatigue) to 10 (worst
itch/pain/fatigue ever experienced) andfilled out the BVS and
PANAS.
In order to standardize the participants’ wrist temper-
ature, which could influence electrical conductivity [53],
subjects held their wrists for 3 minutes in a warm water
bath made at 34∘C [see also [37, 42]], before the electrical
stimulation. The side of itch and pain stimulation (left and
right wrist or vice versa) was randomized across participants.
Then, the step-up procedures for itch and pain were carried
out in random order to determine the individual intensity
of the itch and pain stimuli. At the individually determined
intensity, baseline itch and pain stimuli were applied for 35
seconds. Right before the SAT, participants were asked to
position their index fingers of the left and right hand on
the left and right response button, respectively. They were
instructed to focus on the visual stimuli and to respond
as quickly as possible to the location of a target LED
illuminating, by pressing the response button at the ipsilateral
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side. Before each block, participants were informed whether
they would receive a pain stimulus (i.e., pain block), an itch
stimulus (i.e., itch block), or no stimulus at all (i.e., control
block). At the start of each block, the experimenter counted
down from 3 to 0, to indicate the onset (at 0) of a block.
Directly following each block, participants were asked to
retrospectively report the levels of itch and pain that were
evoked (irrespective of any ongoing spontaneous itch or pain)
during the block on NRSs ranging from 0 (no itch/pain) to 10
(worst itch/pain ever experienced). After all measurements,
participants indicated the perceived threat of the itch and
pain stimuli and the extent to which they were distracted
during their task performance to respond to the visual targets.
After a short debriefing, participants received a monetary
reimbursement.
2.6. Statistical Analyses. Reaction times (RT) for trials with
RT ≥ 150ms (0.2% of the trials were excluded) and trials
with correct responses (0.6% of the trials were excluded)
were extracted from E-prime. Data of two participants were
excluded [fire alarm evacuation (𝑛 = 1), problems with itch
stimulation (𝑛 = 1)] because ≤70% of the RT data was
available [38]. Using Matlab and Statistics Toolbox Release
2012b (The MathWorks, Inc., Natick, Massachusetts, USA)
the mean RT per trial type (i.e., ipsilateral and contralateral
trials during pain, itch, and control blocks) were calculated
per participant. Participants’ accuracy for the SAT was
checked, and no one’s data had to be removed based on the
criterion of >30% mistakes [38]. Additionally, RT per trial
type were calculated for three consecutive time segments of
the 35 s SAT blocks. Three was the maximum number of
segments the blocks could be split into to remaining sufficient
observations per trial type.
All variables to be included in the statistical analyses
were checked for normal distribution and transformed when
necessary. Transformation did not result in normal distri-
bution of the NRS itch and pain scores during the control
blocks and assumptions for the majority of psychological
characteristics were not met. In addition, there were two
participants displaying outlying RT (i.e., >3 SD of the overall
mean) for the majority of the trial types. Therefore, the
analyses were conducted both in all 51 participants and after
excluding the two outliers (𝑛 = 49) combined with log-
transforming variables.
A manipulation check, to confirm that the intended
sensations had been induced in the respective blocks, was
conducted comparing the NRS itch and pain scores for the
itch and pain blocks, respectively, to the control blocks using
nonparametric sign tests. Similarly, NRS unpleasantness rat-
ings were exploratorily compared across the different block
types. An attentional bias index (AB-index)was calculated for
itch and pain [20] using the formula RTcontralateral−RTipsilateral,
during itch and pain blocks, respectively. A positive AB-
index indicated that attention was directed ipsilaterally to the
stimulus location (attentional engagement), while a negative
AB-index indicated that attention was directed contralat-
erally to the stimulus location (attentional disengagement).
One-sample t-tests were conducted to assess whether the
AB-indices significantly differed from zero, that is, implying
attentional bias. In order to test the main hypothesis of
whether participants focused attention on the itch and pain
location, two repeated measures analyses of variance (RM-
ANOVAs) were carried out with the within-subjects factors
location (ipsilateral versus contralateral) and block type
(either itch or pain versus control). Separate analyses for
itch and pain were required because the factor location in
the control blocks referred to the location of the attached
itch and pain electrodes, which were oppositely attached,
and, consequently, for control blocks, the ipsilateral location
was indecisive. Main effects of location and block type were
calculated, as well as location × block type interactions.
Exploratorily, a similar RM-ANOVA was conducted to com-
pare the RT for the itch versus pain blocks (control blocks
were not included). In order to investigate the course of
attention allocation over time, 2 × 2 × 3 RM-ANOVAs were
conducted, for itch and pain separately, with the within-
subjects factors location (ipsilateral versus contralateral),
block type (either itch or pain vs. control), and time (first,
second, and third time segment of blocks). Main effect of
time and location × block type × time interactions were
calculated. For all RM-ANOVAs, a generalized eta squared
was calculated [54, 55].
Finally, Pearson correlation coefficients were calculated
between the AB-indices for itch and pain. Nonparametric
correlation coefficients (Spearman) were calculated between
the psychological characteristics (EPQ-RSS-n, BVS, BSQ-f,
PVAQ-A, PCS-A, FPQ-III, attentional focus on and disen-
gagement from itch and pain, and perceived threat of the
stimuli) and itch and pain AB-indices.
Statistical analyses were conducted using SPSS 23.0 soft-
ware (IBM SPSS Statistics for Windows, Armonk, NY, USA).
All values displayed are means ± SD, unless stated otherwise.
A 𝑝 < 0.05 was considered statistically significant.
3. Results
3.1. Participants. The baseline levels of itch, pain, and fatigue
and outcomes of self-report questionnaires measuring the
psychological characteristics of the 53 participants included
are displayed in Table 1.The reasons for baseline spontaneous
itch levels >0 (𝑛 = 10 in total, MNRS-itch>0 = 1.1 ± 0.5, ranging
from 0.5 to 2.0) were talking/thinking about itch as a result
of this specific question (𝑛 = 5), dry skin (𝑛 = 2), sweating
due to traveling (𝑛 = 1), epilated armpit (𝑛 = 1), and some
skin irritation (𝑛 = 1). The reasons for baseline spontaneous
pain levels >0 (𝑛 = 8 in total;𝑀NRS-pain>0 = 1.1 ± 0.5, ranging
from 0.3 to 2.0) were sore throat (𝑛 = 2), muscle ache (𝑛 = 2),
back ache (𝑛 = 1), knee pain resulting from surgery some
weeks ago (𝑛 = 1), menstruation pain (𝑛 = 1), and finger cut
(𝑛 = 1).
3.2. Manipulation Check: Induced Itch and Pain. The itch,
pain, and unpleasantness scores for the baseline itch and
pain stimuli and those during the SAT blocks are displayed
in Table 2. Nonparametric sign tests showed that median
NRS itch scores were significantly higher during itch than
control blocks of the SAT and median NRS pain scores
were significantly higher during pain than control blocks
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Table 1: Total scores of self-reported questionnaires (𝑛 = 53).
Mean score ± SD Range
Level of spontaneous itch at baseline 0.2 ± 0.5 0.0–2.0
Level of spontaneous pain at baseline 0.2 ± 0.4 0.0–2.0
Level of fatigue at baseline 1.8 ± 1.3 0.0–5.5
Affect
Anxiety (HADS-Anxiety) 2.4 ± 0.5 0.9–3.0
Depression (HADS-Depression) 2.7 ± 0.3 1.9–3.0
Personality characteristics
Neuroticism (EPQ-RSS) 3.2 ± 2.5 0–11.0
Attention to bodily sensations
Attentional focus on itch 2.2 ± 1.9 0–6.5
Attentional focus on pain 3.3 ± 2.4 0–8.0
BVS 2.8 ± 1.5 0.2–6.8
BSQ 2.0 ± 0.5 1.3–3.3
PVAQ-A 24.2 ± 9.5 4–45
Catastrophizing
PCS-A 7.5 ± 6.4 0–29
Fear of pain
FPQ-III 63.3 ± 15.9 36–101
Attentional disengagement from
Itch 4.3 ± 1.0 1–5
Pain 4.0 ± 0.9 1–5
HADS: Hospital Anxiety and Depression Scale (theoretical range 0–21 per subscale); EPQ-RSS: Eysenck Personality Questionnaire revised short scale
(theoretical range 0–12 neuroticism subscale); Single items assessing attentional focusing on itch and pain (theoretical range 0–10); BVS: Body Vigilance
Scale (theoretical range 0–10); BSQ: Body Sensations Questionnaire (theoretical range 1–5); PVAQ-A: Pain Vigilance and Awareness Scale, adjusted for
physical sensations (theoretical range 0–80); PCS-A: Pain Catastrophizing Scale, adjusted for physical sensations (theoretical range 0–52); FPQ: Fear of pain
questionnaire (theoretical range 30–150); single items about attentional disengagement (theoretical range 1–5).
Table 2: Means ± standard deviations of NRS itch, pain, and unpleasantness scores at baseline and during the pain, itch and control blocks
of the somatosensory attention task (SAT) (𝑛 = 51).
NRS itch NRS pain NRS unpleasantness
Baseline itch stimulus 3.5 ± 2.2 0.6 ± 1.1 2.3 ± 2.0
Baseline pain stimulus 0.9 ± 1.3 3.9 ± 1.7 3.4 ± 1.8
SAT itch blocks 1.8 ± 1.6 0.2 ± 0.4 1.2 ± 1.5
SAT pain blocks 0.5 ± 0.8 3.0 ± 1.7 2.7 ± 1.7
SAT control blocks 0.1 ± 0.2 0.0 ± 0.1 0.0 ± 0.1
Note.The electrical current at which the itch and pain stimuli were applied was tailored to individual sensitivity andwas identical during baselinemeasurements
and the SAT. NRS: numerical rating scale.
(both 𝑝 < 0.0005). Median NRS unpleasantness scores were
significantly higher during itch and pain blocks than during
control blocks (both𝑝 < 0.0005) and also significantly higher
during pain blocks than during itch blocks (𝑝 < 0.0005).
3.3. Perceived Threat of the Stimuli. The induced pain and
itch were, on average, perceived as 2.8 ± 2.4 and 1.5 ± 1.8
threatening, respectively. With regard to the degree to which
participants were distracted from the task to respond to the
visual targets, they indicated to be distracted by the itch and
pain stimuli on average 3.2 ± 1.0 and 2.5 ± 1.1, respectively,
and 1.8 ± 0.6 by other factors.
3.4. Behavioral Outcomes. With regard to the accuracy, the
average number of mistakes made during the SAT over all
participants was 0.6± 1.3 (range 0 to 8; theoretical maximum
120), with overall 0.5%mistakes during itch blocks, 0.4%mis-
takes during pain blocks, and 0.6% mistakes during control
blocks.ThemeanRTs (of correct responses) during itch, pain,
and control blocks for the ipsilateral and contralateral trials
are displayed in Table 3.
The location × block type interaction effect was of pri-
mary interest to this study as this indicated whether attention
was drawn to the stimulus location. For itch, the RM-
ANOVA comparing the ipsilateral and contralateral trials
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Table 3: Mean reaction times (in ms) ± standard deviation for the ipsilateral and contralateral trials of the somatosensory attention task
(SAT) during itch, pain, and control blocks (𝑛 = 51).
Mean reaction times (ms) of ipsilateral trials Mean reaction times (ms) of contralateral trials
Itch blocks 466.2 ± 91.0 463.7 ± 84.4
Pain blocks 470.7 ± 81.8 472.5 ± 80.9
Control blocks 450.4 ± 81.21 457.4 ± 88.52
1Reaction times during control blocks (no somatosensory stimulation) ipsilateral to attached itch electrodes location. 2Reaction times during control blocks
(no somatosensory stimulation) ipsilateral to the attached pain electrodes location.
(factor 1: location) during the itch and control blocks (factor
2 block type) did not show a significant location × block
type interaction effect (𝐹(1, 50) = 0.78, 𝑝 = 0.38, 𝜂G
2 =
0.0014).There was, however, a significant main effect of block
type (𝐹(1, 50) = 12.80, 𝑝 < 0.001, 𝜂G
2 = 0.019), with longer
RT for itch blocks than control blocks. The main effect of
location was not significant (𝐹(1, 50) = 0.13, 𝑝 = 0.72, 𝜂G
2 =
0.0003). For pain, the RM-ANOVA did not show a significant
interaction effect of location × block type (𝐹(1, 50) = 0.71,
𝑝 = 0.41, 𝜂G
2 = 0.00012). Again, there was a significant main
effect of block type (𝐹(1, 50) = 21.29, 𝑝 < 0.0001, 𝜂G
2 = 0.05),
with longer RT for pain blocks than for control blocks, but no
significant main effect of location (𝐹(1, 50) = 0.16, 𝑝 = 0.69,
𝜂G
2 = 0.00032). After removing the two outliers, similar levels
of significance were obtained. In line with the main findings
of the nonsignificant location × block type interaction, no
significant attentional biases were found as theAB-indices for
itch (𝑡(50) = −0.51, 𝑝 = 0.61) and pain (𝑡(50) = 0.18, 𝑝 = 0.86)
did not significantly differ from zero.
Explorative comparison of the itch and pain blocks
showed no significant interaction effect of location × block
type (𝐹(1, 50) = 0.13, 𝑝 = 0.72, 𝜂G
2 = 0.00036), nor a
significant main effect of location (𝐹(1, 50) = 0.004, 𝑝 =
0.952, 𝜂G
2 = 0.00001), but the overall RT were significantly
longer for the pain than for the itch blocks (𝐹(1, 50) = 5.26,
𝑝 = 0.026, 𝜂G
2 = 0.0109).
3.5. Time Course of Attention during the SAT. In a further
analysis of the data, Figure 2 displays the RT for the ipsilateral
and contralateral trials during the itch (Figure 2(a)), pain
(Figure 2(b)), and control (Figure 2(c)) blocks, which are
subdivided into three equal time segments. For itch, there
was no significant location × block type × time interaction
(𝐹(2, 100) = 2.01, 𝑝 = 0.140, 𝜂G
2 = 0.0068), but a significant
main effect of time (𝐹(2, 100) = 3.77, 𝑝 = 0.026, and
𝜂G
2 = 0.015) emerged. Simple contrast analyses showed that
RT were significantly faster in the second than in the first
segment (𝐹(1, 50) = 6.73, 𝑝 = 0.012 and, 𝜂G
2 = 0.006). There
were no significant differences in RT when comparing the
second with the third segment, although a nonsignificant
trend was observed (𝐹(1, 50) = 4.03, 𝑝 = 0.050, and 𝜂G
2 =
0.038), or when comparing the first and the third segment
(𝐹(1, 50) = 0.48, 𝑝 = 0.494, and 𝜂G
2 = 0.0094). For pain, there
was no significant location × block type × time interaction
(𝐹(2, 100) = 0.41, 𝑝 = 0.662, and 𝜂G
2 = 0.0012), nor a
significantmain effect of time, although a trend was observed
(𝐹(2, 100) = 2.99, 𝑝 = 0.055, and 𝜂G
2 = 0.012).
After removing the two outliers, similar results were
obtained in the 2 × 2 × 3 RM-ANOVA for itch. For pain
results were also comparable after removing the two outliers,
although now a significant main effect of time (𝐹(2, 96) =
3.17, 𝑝 = 0.047, and 𝜂G
2 = 0.015) was found. Simple contrast
analyses showed significantly faster RT in the second than in
the first segment (𝐹(1, 48) = 7.30, 𝑝 = 0.010, and 𝜂G
2 = 0.026),
but no significant differences in the second compared to the
third segment (𝐹(1, 48) = 1.43, 𝑝 = 0.237, and 𝜂G
2 = 0.011)
nor in the first compared to the third segment (𝐹(1, 48)= 1.54,
𝑝 = 0.221, and 𝜂G
2 = 0.019).
3.6. Exploratory Analyses: Association between Individual
Characteristics and Attentional Bias towards Itch and Pain.
TheAB-index for itch was on average −2.9 ± 39.9 and ranged
from −80.1 to 90.2; 39.2% of the participants displayed a pos-
itive AB-index (i.e., towards the itch stimulus location). The
AB-index for pain was on average 1.0±41.0 and ranged from
−79.5 to 86.5; 54.9% of the participants displayed a positive
AB-index (i.e., towards the pain stimulus location). The AB-
indices for itch and pain were not significantly correlated
(R = −.252, 𝑝 = 0.074). The AB indices were generally
not significantly correlated with the psychological charac-
teristics neuroticism (EPQ-RSS), catastrophizing of physical
sensations (PCS-A), fear of pain (FPQ-III), self-reported
attention to itch and pain and to bodily sensations in general
(BVS, BSQ, PVAQ-A), attentional disengagement from itch
and pain, and the perceived threat of the induced itch and
pain. Only four significant correlations were observed. There
were positive associations between the AB-index for itch and
catastrophizing (𝑟
𝑆
= 0.40, 𝑝 = 0.003), neuroticism (EPQ-
RSS-n) (𝑟
𝑆
= 0.37, 𝑝 = 0.008), and the threat value of the
itch stimulus (𝑟
𝑆
= 0.29, 𝑝 = 0.04). There was a negative
association between the AB-index for pain and the threat
value of the pain stimulus (𝑟𝑆 = −0.30, 𝑝 = 0.03).
4. Discussion
The present study investigated whether attention of healthy
volunteers would be spatially drawn to the stimulus location
early on during tonic itch and pain stimuli, and, whether they
would disengage their attention away from the stimulated
location later on during stimulation. In the somatosensory
attention task, participants received tonic somatosensory
itch or pain stimuli or no stimulation while responding to
the location of visual targets, either ipsi- or contralaterally
displayed to the somatosensory location. In contrast with our
expectations, no significant differences were found between
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Figure 2: Reaction times (in ms) for participants (𝑛 = 51) responding to the visual target lights during the 35 s somatosensory itch (a) or
pain bocks (b) or in control blocks, in which no somatosensory stimulation was applied (c). Visual targets were displayed either at the side
of the itch or pain stimulation (i.e., ipsilateral trials, solid black line) or at the opposite side (i.e., contralateral trials, dashed grey line). In the
case of control blocks, the solid black line is indicative for trials ipsilaterally to the attachment of the itch electrodes and the dashed grey line
is indicative for trials ipsilaterally to the attachment of the pain electrodes.
responding to visual targets ipsilaterally compared to con-
tralaterally to the stimulation, neither over the total duration
of stimulation nor across the three successive time segments
during the tonic itch and pain stimuli. Of further note, we
observed that itch and pain stimulation slowed down partic-
ipants’ task performance (i.e., responding to visual targets)
compared to no stimulation, indicating towards attentional
interference by itch and pain. Overall, these results seem
to indicate that itch and pain affect attentional processes,
but that attention is not systematically directed towards
nor disengaged from the location of tonic itch and pain
stimulation.
There were no indications that attention was directed
away from or towards the location of the itch and pain
stimulation: reaction times for ipsilateral and contralateral
trials did not significantly differ, nor was there a significant
difference in spatial attention allocation between itch and
pain. The indications for an attentional disengagement effect
during the last part of the 35 s itch stimulation in our previous
study [38] could not be confirmed here. In addition, we were
also not able to replicate previous findings that pain directs
attention towards its spatial location [19–27]. However, most
of these studies used phasic pain stimuli with each trial
consisting of one pain stimulus and one target stimulus [19–
26] or pain stimuli of maximally 10 seconds [27]. It could be
that the 35 s somatosensory stimuli in the present study along
with multiple trials of visual targets during that stimulus may
not draw attention to the stimulus location for the entire
time frame. Attention likely continuously shifted between
the somatosensory stimuli and visual targets. This process
may have been enhanced because the participants were
aware that the visual targets could be displayed ipsilateral or
contralateral to the stimulation and the central fixation light
before each trial could have influenced attention allocation.
Moreover, the intensity of the itch and pain stimuli and
the threatening character of the stimuli were relatively mild,
and therefore the stimulus saliency may have been limited.
Generally, in the present and the previous study there was a
time effect showing that participants responded faster after
the first segment. This may be owing to a learning effect as
the participants learned to respond faster to the visual targets,
leaving less attention to focus on the itch and pain sensations.
This effect was, however, irrespective of the spatial location
of the somatosensory stimuli. It could be that somatosensory
stimuli only draw attention to the spatial location in the very
beginning. However, the current segmentation of three time
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segments might not be sufficiently fine-grained to determine
continuous attentional shifts.
Of further note, our study did show that participants
were generally slower in task performance of responding
to the targets during itch and pain, which is indicative for
attentional interference by itch and pain. The fact that pain
interferes with attention has previously been demonstrated
[13–18] although most studies used stimuli with a duration
shorter than 35 s. Surprisingly, in our previous study with itch
stimuli similar to those in the present study we did not find
such an interference effect [38]. Exploratory findings indicate
that pain may interfere more in attentional processing than
itch, as overall reaction times (i.e., independent of stimulus
location) were slower during pain than during itch. Expla-
nations for this may include that pain is evolutionarily more
aversive, as indicated by the higher reported threat value
and unpleasantness of the pain stimuli presented here and,
consequently, a higher saliency [10, 12]. However, it could
also be related to the lower levels of evoked itch than pain.
Reversely, participants may have better been able to ignore
the itch and therefore perceived itch less intense during the
attention task, akin previous findings showing that focusing
away from pain can result in less intense pain [27, 56].
Support for this explanation comes from the large decline in
itch when comparing the itch stimuli, at the same intensity,
given at baseline and during the attention task. Another
possible explanation could be that people habituate more
easily to itch than to pain, but this has, to our knowledge, not
yet been investigated.
Of the psychological characteristics the individual levels
of catastrophizing of physical sensations and neuroticism
were related to a higher attentional bias index for itch. How-
ever, given the nonsignificant association between catastro-
phizing and the attentional bias index for pain, these findings
should be interpreted with caution. There were also some
indications that higher perceived threat of the itch stimulus
was related to a higher attentional bias index for itch, but
higher perceived threat of the pain stimulus was associated
with a lower attentional bias index for pain, which is contrary
to what would be expected. Other psychological character-
istics, including fear of pain and self-reported attention to
and disengagement from physical sensations and itch and
pain in particular, did not play a role in attention allocation
towards the itch and pain stimuli. Future research should
further investigate the role of individual characteristics in
spatial attention allocation towards itch and pain.
This study has several limitations. First, the levels of itch
induced during the attention task were relatively low and not
directly comparable to pain. Second, after each block in the
SAT, participants retrospectively rated the intensity of itch
and pain during the somatosensory stimulation. It cannot
be ruled out that participants also intentionally focused
on the stimulation while responding to the visual targets.
Third, the current design did not allow the investigation of
fast attentional switches between somatosensory and visual
stimuli. Future research may use more fine-grained time
segments. Fourth, the included group was homogenous with
respect to age but this limits extrapolation to other age
groups.
5. Conclusions
This study showed that although tonic itch and pain stimuli
interfere with task performance, attention is not consistently
drawn towards their spatial location, probably because atten-
tion shifts over the time course of tonic stimuli. Additional
research focusing more closely on time aspects of attention
allocation is required to elucidate how tonic itch and pain
stimuli are being processed in healthy participants and in
clinical populations.When focusing attention on the location
of itch or pain aggravates symptoms, patients with chronic
itch and pain may benefit from learning to disengage their
attention away from itch or pain, respectively.
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